Congenica

OverviewSuggest Edit

Congenica is a UK start-up company founded on pioneering research from the Wellcome Trust Sanger Institute, NHS clinicians and genetic testing laboratories. We are translating this research into a revolutionary clinical genomic analytics platform, Sapientia, for processing genome-wide data sets of human DNA sequence with deep clinical phenotype information in order to provide a definitive molecular diagnosis and clinically actionable interpretation for treatment, patient stratification and improved therapeutic discoveries.

TypePrivate
Founded2014
HQHinxton, GB
Websitecongenica.com
Employee Ratings3.5

Latest Updates

Employees (est.) (Aug 2022)97(-3%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Congenica

David Atkins

David Atkins

Chief Executive Officer
Nick Lench

Nick Lench

Co-Founder
Andy Richards

Andy Richards

Chairman
Matthew Hurles

Matthew Hurles

Non-Executive Director
David Shi

David Shi

Non-Executive Director
Michael Anstey

Michael Anstey

Board Member
Show more

Congenica Office Locations

Congenica has an office in Hinxton
Hinxton, GB (HQ)
Wellcome Trust Genome Campus
Show all (1)

Congenica Financials and Metrics

Summary Metrics

Founding Date

2014

Congenica total Funding

$82.2 m

Congenica latest funding size

$50 m

Time since last funding

2 years ago

Congenica investors

Congenica's latest funding round in November 2020 was reported to be $50 m. In total, Congenica has raised $82.2 m
Show all financial metrics

Congenica Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Congenica Online and Social Media Presence

Embed Graph

Congenica News and Updates

GenomOncology and Congenica announce collaborative development of novel Precision Oncology Solution

CLEVELAND, Aug. 4, 2022 /PRNewswire/ -- Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for the development of a novel ground-breaking CE-IVD Precision Oncology...

Congenica Appoints Dr. Tom Barber as Chief Scientific Officer

Congenica Appoints Dr. Tom Barber as Chief Scientific Officer

Congenica to Provide Tertiary Analysis for Whole Genome Sequencing for Hong Kong Genome Project

Congenica to Provide Tertiary Analysis for Whole Genome Sequencing for Hong Kong Genome Project

Congenica Expands its Clinical Consulting Services

Congenica Expands its Clinical Consulting Services

Congenica is Joint Winner of MIT Solve Horizon Prize

Congenica is Joint Winner of MIT Solve Horizon Prize

Congenica Receives CE Mark for Genomic Analysis Software

Congenica Receives CE Mark for Genomic Analysis Software
Show more

Congenica Blogs

Mental health in the rare disease community

Congenica and partners respond to the UK Government’s open consultation to support mental health and wellbeing     A collaboration between Congenica, Gene People, Rareminds CIC, UCL Great Ormond Street Institute of Child Health and Addenbrooke’s Hospital, highlights the mental health a…

Congenica appoints Robert Denison as CEO

Cambridge, United Kingdom –22 June 2022  - Congenica, a digital health company that enables precision medicine through its world - leading diagnostic decision support platform for genomic data, today announces the appointment of Robert Denison as Chief Execut…

Unlocking sociocultural and community factors for the global adoption of genomic medicine

Dr Charles Steward, Patient and Advocacy and Engagement (PAE) lead at Congenica, talks about the latest article that he and members of the PAE Board co-authored and has now published in the Orphanet Journal of Rare Diseases   Advances in genomic medicine are incr…

Congenica wins Technology Company of the Year

Cambridge, United Kingdom – 12 May 2022 - Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomic data, has won the award for Technology Company of the Year at the 2022 Cambridge Independent Science and T…

Discovering Primary Ciliary Dyskinesia (PCD)

Fiona Copeland is mother to two boys with the same rare disease, Primary Ciliary Dyskinesia (PCD) - a disease that she knew nothing about until the boys received results of a genetic diagnosis at the ages of six and four. Here she shares her story of discovering PCD.   Poorly babie…

The Hong Kong Genome Project: Benefits to Patients

The following article has been written for Congenica by by Mr. K. P. Tsang, Chairman, Rare Disease Hong Kong, supported by Zeng Jianping, following the news that Congenica is to provide Tertiary Analysis for Whole Genome Sequencing for Hong Kong Genome Project.
Show more

Congenica Frequently Asked Questions

  • When was Congenica founded?

    Congenica was founded in 2014.

  • Who are Congenica key executives?

    Congenica's key executives are David Atkins, Nick Lench and Andy Richards.

  • How many employees does Congenica have?

    Congenica has 97 employees.

  • Who are Congenica competitors?

    Competitors of Congenica include DEINOVE, Codex DNA and Atlas Biomed.

  • Where is Congenica headquarters?

    Congenica headquarters is located at Wellcome Trust Genome Campus, Hinxton.

  • Where are Congenica offices?

    Congenica has an office in Hinxton.

  • How many offices does Congenica have?

    Congenica has 1 office.